Bath & Body Works, Inc. (BBWI)
| Market Cap | 4.12B -22.5% |
| Revenue (ttm) | 7.21B -2.2% |
| Net Income | 781.00M +7.3% |
| EPS | 3.85 +13.7% |
| Shares Out | 201.65M |
| PE Ratio | 5.31 |
| Forward PE | 7.96 |
| Dividend | $0.80 (3.92%) |
| Ex-Dividend Date | Aug 21, 2026 |
| Volume | 4,569,316 |
| Open | 20.76 |
| Previous Close | 20.55 |
| Day's Range | 20.12 - 20.78 |
| 52-Week Range | 14.28 - 27.40 |
| Beta | 1.40 |
| Analysts | Hold |
| Price Target | 24.06 (+17.83%) |
| Est. Earnings | Nov 19, 2026 |
About BBWI
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the... [Read more]
Financial Performance
In fiscal year 2026, Bath & Body Works's revenue was $7.29 billion, a decrease of -0.22% compared to the previous year's $7.31 billion. Earnings were $649.00 million, a decrease of -18.67%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for BBWI stock is "Hold." The 12-month stock price target is $24.06, which is an increase of 17.83% from the latest price.
News
LandBridge Announces Completion of Conversion and Redomestication in Texas
HOUSTON--(BUSINESS WIRE)--LandBridge Corporation (NYSE: LB; NYSE Texas: LB) (“LandBridge” or the “Company”) today announced that it has completed its previously announced conversion and redomesticatio...
LandBridge Schedules Third Quarter Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE TX: LB) ("LandBridge") today announced that it will release its financial results for the third quarter of 2026 after market close on W...
Bath & Body Works announces launch of Essentials, a new body care franchise
Bath & Body Works is launching Essentials, a new body care franchise that pairs hypoallergenic formulas made for sensitive skin with close-to-skin fragrance. The collection introduces two new formulas...
LandBridge Announces Pricing of Upsized $125,000,000 Offering of Additional 6.250% Senior Notes due 2030
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE Texas: LB) (“LandBridge”) announced today that DBR Land Holdings LLC (the “Issuer”), a subsidiary of LandBridge, has priced its offerin...
LandBridge Announces Launch of $100,000,000 Offering of Additional 6.250% Senior Notes due 2030
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE Texas: LB) (“LandBridge”) announced today that DBR Land Holdings LLC (the “Issuer”), a subsidiary of LandBridge, intends, subject to ma...
Bath & Body Works initiated with a Market Perform at BMO Capital
BMO Capital initiated coverage of Bath & Body Works with a Market Perform rating and $20 price target The firm views new CEO Daniel Heaf’s “Consumer First Formula” plan as…
Bath & Body Works price target lowered to $21 from $24 at JPMorgan
JPMorgan analyst Matthew Boss lowered the firm’s price target on Bath & Body Works to $21 from $24 and keeps a Neutral rating on the shares.
Bath & Body Works price target lowered to $22 from $23 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Bath & Body Works to $22 from $23 and keeps a Hold rating on the shares.
Bath & Body Works price target lowered to $20 from $22 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Bath & Body Works to $20 from $22 and keeps an Equal Weight rating on the shares. Q2 was “modestly better” and…
Bath & Body Works price target lowered to $17 from $19 at UBS
UBS lowered the firm’s price target on Bath & Body Works to $17 from $19 and keeps a Neutral rating on the shares. The Q2 earnings report looks like a…
Bath & Body Works price target lowered to $23 from $25 at Baird
Baird lowered the firm’s price target on Bath & Body Works to $23 from $25 and keeps a Neutral rating on the shares. The firm updated its model following Q2…
Bath & Body Works price target lowered to $24 from $26 at Wells Fargo
Wells Fargo lowered the firm’s price target on Bath & Body Works to $24 from $26 and keeps an Overweight rating on the shares. The firm says Q2 showed that…
Bath & Body Works price target lowered to $22 from $23 at Barclays
Barclays lowered the firm’s price target on Bath & Body Works to $22 from $23 and keeps an Equal Weight rating on the shares post the Q2 report. The company’s…
Bath & Body Works Stock (BBWI) Climbs 7% After Forecast-Busting Q2 Earnings
Shares in Bath & Body Works ($BBWI) roared 7% higher today after it reported forecast-busting Q2 sales helped by digital and teenage demand. The personal care and home fragrance retailer…
Bath & Body Works Earnings Call Transcript: Q2 2027
Second quarter results exceeded expectations, with net sales down 2.3% and adjusted EPS of $0.62, aided by tariff refunds. Digital and expanded distribution channels showed growth, while guidance for full-year sales and earnings was raised. Strategic investments continue to support long-term transformation.
Bath & Body Works Earnings release: Q2 2027
Bath & Body Works released its Q2 2027 earnings on August 26, 2026, summarizing the period's financial results.
Bath & Body Works Slides: Q2 2027
Bath & Body Works has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on August 26, 2026.
Bath & Body Works Quarterly report: Q2 2027
Bath & Body Works has published its Q2 2027 quarterly earnings report on August 26, 2026.
Bath & Body Works Raises Earnings Outlook on Higher Profit
The soaps and fragrances retailer said it now expects annual adjusted earnings per share to be $2.60 to $2.80, up from prior guidance of $2.40 and $2.65.
Bath & Body Works sees FY26 adjusted EPS $2.60-$2.80, consensus $2.65
Narrows FY26 net sales view to decline (4%)-(2.5%) compared to $7.291B in FY25. There are no share repurchases assumed in our outlook. In FY26, we now expect to generate free…
Bath & Body Works sees Q3 adjusted EPS 7c-12c, consensus 26c
Sees Q3 net sales down (5%)-(2.5%) compared to $1.594B last year.
Bath & Body Works reports Q2 adjusted EPS 62c, consensus 24c
Reports Q2 revenue $1.51B, consensus $1.50B. Daniel Heaf, CEO of Bath & Body Works, commented, “Our Q2 results exceeded our sales and earnings per share guidance. Underlying business trends remain…
Bath & Body Works lifts annual profit forecast as digital demand offsets weak store traffic
Bath & Body Works on Wednesday raised its forecast for full-year profit and beat estimates for second-quarter results, benefiting from demand for body care products and home fragrances on digital ch...
Bath & Body Works Reports Second Quarter Results Exceeding Guidance and Continued Progress on Transformation
Delivers Q2 net sales and adjusted earnings per share results above guidance Second quarter net sales of $1.5 billion, down 2.3%. Earnings per diluted share of $0.58; Adjusted earnings per diluted sha...
Bath & Body Works Reports Q2 Earnings Tomorrow – Who Owns BBWI Stock?
Bath & Body Works ($BBWI) reports its Q2 earnings tomorrow – August 26. Its share price is down nearly 2% in the year-to-date, but up nearly 8% in the last…